tiprankstipranks
Trending News
More News >
Avanos Medical (AVNS)
NYSE:AVNS
Advertisement

Avanos Medical (AVNS) Stock Statistics & Valuation Metrics

Compare
173 Followers

Total Valuation

Avanos Medical has a market cap or net worth of $537.34M. The enterprise value is $613.71M.
Market Cap$537.34M
Enterprise Value$613.71M

Share Statistics

Avanos Medical has 46,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,402,480
Owned by Insiders2.51%
Owned by Institutions27.21%

Financial Efficiency

Avanos Medical’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -37.22%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-37.22%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee308.85K
Profits Per Employee-176.07K
Employee Count2,227
Asset Turnover0.60
Inventory Turnover2.21

Valuation Ratios

The current PE Ratio of Avanos Medical is 45.8. Avanos Medical’s PEG ratio is ―.
PE Ratio45.8
PS Ratio
PB Ratio
Price to Fair Value0.88
Price to FCF
Price to Operating Cash Flow4.54
PEG Ratio

Income Statement

In the last 12 months, Avanos Medical had revenue of 687.80M and earned -392.10M in profits. Earnings per share was -8.53.
Revenue687.80M
Gross Profit381.30M
Operating Income-396.20M
Pretax Income-403.30M
Net Income-392.10M
EBITDA-345.60M
Earnings Per Share (EPS)-8.53

Cash Flow

In the last 12 months, operating cash flow was 113.40M and capital expenditures -25.50M, giving a free cash flow of 87.90M billion.
Operating Cash Flow113.40M
Free Cash Flow87.90M
Free Cash Flow per Share1.89

Dividends & Yields

Avanos Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.93
52-Week Price Change-50.83%
50-Day Moving Average11.62
200-Day Moving Average14.26
Relative Strength Index (RSI)57.86
Average Volume (3m)706.70K

Important Dates

Avanos Medical upcoming earnings date is Oct 29, 2025, Before Open (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend Date

Financial Position

Avanos Medical as a current ratio of 2.37, with Debt / Equity ratio of 17.69%
Current Ratio2.37
Quick Ratio1.53
Debt to Market Cap0.20
Net Debt to EBITDA-0.18
Interest Coverage Ratio-32.48

Taxes

In the past 12 months, Avanos Medical has paid -17.00M in taxes.
Income Tax-17.00M
Effective Tax Rate0.04

Enterprise Valuation

Avanos Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of 9.59.
EV to Sales1.16
EV to EBITDA-2.30
EV to Free Cash Flow9.59
EV to Operating Cash Flow7.89

Balance Sheet

Avanos Medical has $90.30M in cash and marketable securities with $137.30M in debt, giving a net cash position of $47.00M billion.
Cash & Marketable Securities$90.30M
Total Debt$137.30M
Net Cash$47.00M
Net Cash Per Share$1.01
Tangible Book Value Per Share$5.67

Margins

Gross margin is 53.83%, with operating margin of -57.60%, and net profit margin of -57.01%.
Gross Margin53.83%
Operating Margin-57.60%
Pretax Margin-58.64%
Net Profit Margin-57.01%
EBITDA Margin-50.25%
EBIT Margin-56.86%

Analyst Forecast

The average price target for Avanos Medical is $11.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$11.00
Price Target Upside-7.33% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast1.48%
EPS Growth Forecast-6091.13%

Scores

Smart Score6
AI Score48
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis